Deep learning

Serket and Powerful Medical Win the 2021 UiPath Automation Awards with Automation for Good Solutions

Monday, October 25, 2021 - 1:00pm

UiPath (NYSE: PATH), a leading enterprise automation software company, today announced the winners of the UiPath Automation Awards 2021 Central and Eastern Europe and Turkey Edition .

Key Points: 
  • UiPath (NYSE: PATH), a leading enterprise automation software company, today announced the winners of the UiPath Automation Awards 2021 Central and Eastern Europe and Turkey Edition .
  • This years winning solutions are aligned with UiPaths goal to support Automation for Good, and exemplify the potential of automation to make a positive impact across industries and on the wider society.
  • Our vision at Powerful Medical is to be at the center of this paradigm change, said Martin Herman, co-founder and CEO of Powerful Medical.
  • UiPath has a vision to deliver the Fully Automated Enterprise, one where companies use automation to unlock their greatest potential.

Deep Bio and ARUP to Conduct a Prospective Study to Evaluate AI Performance in a Real-World Pathology Workflow

Monday, October 25, 2021 - 2:00am

The company will conduct a prospective study to validate the performance of its AI-based prostate cancer diagnosis software, DeepDx Prostate, at ARUP Laboratories, a leading reference laboratory in the US.

Key Points: 
  • The company will conduct a prospective study to validate the performance of its AI-based prostate cancer diagnosis software, DeepDx Prostate, at ARUP Laboratories, a leading reference laboratory in the US.
  • This prospective study is significant in that it validates the overall performance of DeepDx Prostate on real-world patient data," stated Sun Woo Kim, the CEO of Deep Bio.
  • In addition to this study, Deep Bio and ARUP have plans to collaborate on other clinical research related to cancer diagnosis, prognosis, and prediction.
  • Deep Bio Inc. is an AI biotech company with in-house expertise in deep learning, pathology, life sciences, and pharmacotherapeutics.

Latest innovations in RayStation, RayCare and RayIntelligence to be presented at ASTRO 2021

Friday, October 22, 2021 - 2:17pm

STOCKHOLM, Oct. 22, 2021 /PRNewswire/ --RaySearch Laboratories AB (publ) will be showcasing the latest oncology software innovations at ASTRO 2021 , to be held in Chicago, October 24-27.

Key Points: 
  • STOCKHOLM, Oct. 22, 2021 /PRNewswire/ --RaySearch Laboratories AB (publ) will be showcasing the latest oncology software innovations at ASTRO 2021 , to be held in Chicago, October 24-27.
  • Attendees will be able to book demonstrations of RayStation* treatment planning system, RayCare* oncology information system, and RayIntelligence, the new cloud-based analytics system for oncology, during the congress.
  • The latest versions of RayStation (11A) and RayCare (5A) were released in May 2021.
  • The first version of RayIntelligence was released in December 2020, and at ASTRO 2021 the latest version (1C), which has enhanced functionality for analyzing and comparing treatment plans for patient populations, will be presented.

KRAFTON to Globally Launch PUBG: New State on Nov. 11

Friday, October 22, 2021 - 8:00am

"PUBG: NEW STATE inherits the core of the PUBG IP and will have a competitiveness in and of itself on the global market," said CEO of KRAFTON, CH Kim during the online showcase.

Key Points: 
  • "PUBG: NEW STATE inherits the core of the PUBG IP and will have a competitiveness in and of itself on the global market," said CEO of KRAFTON, CH Kim during the online showcase.
  • Additionally, the graphical quality of PUBG: NEW STATE pushes the boundaries of what was previously possible on mobile platforms.
  • Pre-registrations originally opened in February 2021 when KRAFTON formally revealed PUBG: NEW STATE.
  • KRAFTON is responsible for premier entertainment properties including PUBG: BATTLEGROUNDS, PUBG: NEW STATE, The Callisto Protocol, TERA, and ELYON.

KRAFTON to Globally Launch PUBG: New State on Nov. 11

Friday, October 22, 2021 - 8:00am

SANTA MONICA, Calif., OCT. 22, 2021 /PRNewswire/ -- During its an hour-long PUBG: NEW STATE online showcase, KRAFTON, Inc., the creators of PUBG: BATTLEGROUNDS, announced that PUBG: NEW STATE will officially launch on iOS and Android in more than 200 countries on Nov. 11 following a final Technical Test in 28 countries* from October 29 – 30. During the showcase, CH Kim, CEO of KRAFTON, shared opening remarks followed by presentations from Minkyu Park (Executive Producer), Daehun Kim (Creative Director), Henry Chung (Head of Publishing) and Sangwan Kim (Head of Anti-cheat Unit). The company revealed its post-launch support plans for PUBG: NEW STATE, which include a strong and consistent pipeline of new content, global service support and anti-cheat measures. 

Key Points: 
  • "PUBG: NEW STATE inherits the core of the PUBG IP and will have a competitiveness in and of itself on the global market," said CEO of KRAFTON, CH Kim during the online showcase.
  • Additionally, the graphical quality of PUBG: NEW STATE pushes the boundaries of what was previously possible on mobile platforms.
  • Pre-registrations originally opened in February 2021 when KRAFTON formally revealed PUBG: NEW STATE.
  • KRAFTON is responsible for premier entertainment properties including PUBG: BATTLEGROUNDS, PUBG: NEW STATE, The Callisto Protocol, TERA, and ELYON.

Wholesale Investor Launches CRIISP™ AI-Driven Investor-to-Founder Matchmaking Feature

Friday, October 22, 2021 - 12:00am

SYDNEY, Oct. 22, 2021 /PRNewswire/ -- Wholesale Investor, a leading global venture investment platform, announced today the release of its powerful AI-driven matchmaking feature, available to all users with a CRIISP™ account.

Key Points: 
  • Wholesale Investor (WI) proudly launches a new AI-driven matchmaking feature on its capital raising and venture investment platform, CRIISP (Capital Raising Intelligent Investment Platform).
  • Combined with the other capabilities of CRIISP, the AI matchmaking feature significantly reduces inefficiencies that investors commonly experience when sourcing deal flow whilst ensuring founders are placed in front of more relevant investors.
  • SYDNEY, Oct. 22, 2021 /PRNewswire/ -- Wholesale Investor, a leading global venture investment platform, announced today the release of its powerful AI-driven matchmaking feature, available to all users with a CRIISP account.
  • According to Wholesale Investor's Co-Founder and Managing Director Steve Torso, "The launch of our AI-Driven Matchmaking Engine on CRIISP is an exciting and significant milestone for Wholesale Investor and the venture capital ecosystem.

Survey Finds Executional Gap Between Marketing and Sales is Hindering Personalization at Scale for Account-Based Marketing Success

Thursday, October 21, 2021 - 4:30pm

Further, 76% of salespeople believe marketing is doing all they can to support sales teams.

Key Points: 
  • Further, 76% of salespeople believe marketing is doing all they can to support sales teams.
  • The operational silos between sales and marketing only pose further disconnects on the amount of personalization being executed on each account and touchpoint.
  • Personalization is time-consuming: On average, each salesperson is spending 16 hours a week just on researching prospects for personalization.
  • Conversica is the leading provider of Conversational AI solutions that help enterprise marketing, sales, and customer success teams attract, acquire and grow customers at scale across the customer revenue lifecycle.

Biognosys to Present Major Scientific and Technological Advances at the ASMS 2021 Mass Spectrometry Conference

Thursday, October 21, 2021 - 3:00pm

Biognosys, a leading inventor and developer of mass spectrometry-based proteomics solutions, today announced they will be presenting major scientific and technological advances on their proprietary proteomics research services, software, and kits at the American Society for Mass Spectrometry (ASMS) Annual Conference from October 31st to November 4th in Philadelphia (USA).

Key Points: 
  • Biognosys, a leading inventor and developer of mass spectrometry-based proteomics solutions, today announced they will be presenting major scientific and technological advances on their proprietary proteomics research services, software, and kits at the American Society for Mass Spectrometry (ASMS) Annual Conference from October 31st to November 4th in Philadelphia (USA).
  • Biognosys will present a record number of 3 oral presentations, 10 scientific posters, 2 poster collaborations, 1 workshop panel, and 2 Spectronaut breakfast seminars.
  • In addition, their team of scientific experts will be present at booth #224 to answer questions and demo software.
  • Biognosys unique, patented technologies utilize high-resolution mass spectrometry to quantify thousands of proteins across thousands of samples with industry-leading precision, depth, and throughput.

DeviantArt Launches Subscription Service for Artists to Manage and Monetize Their Art from One Protected Platform

Thursday, October 21, 2021 - 2:00pm

The addition of the subscription service joins DeviantArt's recently launched online art protection service and new offers with Wix and BitPay .

Key Points: 
  • The addition of the subscription service joins DeviantArt's recently launched online art protection service and new offers with Wix and BitPay .
  • The subscription service encourages any type of artistfrom photographers to digital artists and storytellersto share never-before-seen art, journals detailing their latest projects, new tutorial videos, custom brush packs, PSD files and more.
  • Alongside the subscription service, DeviantArt is rolling out enhanced Core Membership plans with competitive platform fees ranging from 12% to just 2.5% depending on the plan.
  • Over the past year, DeviantArt has made significant upgrades to the platform, helping artists to better navigate the digital art world.

PathAI Welcomes Two New Executives as it Strengthens its Biopharma Business Leadership Team

Thursday, October 21, 2021 - 2:00pm

BOSTON, Oct. 21, 2021 /PRNewswire/ -- PathAI, a leading provider of AI-powered technology, announces that Saumya Pant, Ph.D., joins PathAI as Vice President, Laboratory Strategy and Operations to lead the newly formed PathAI biopharma laboratory business and Jiayi Hao joins as Vice President to lead the overall Biopharma Business Strategy and Operations teams.

Key Points: 
  • BOSTON, Oct. 21, 2021 /PRNewswire/ -- PathAI, a leading provider of AI-powered technology, announces that Saumya Pant, Ph.D., joins PathAI as Vice President, Laboratory Strategy and Operations to lead the newly formed PathAI biopharma laboratory business and Jiayi Hao joins as Vice President to lead the overall Biopharma Business Strategy and Operations teams.
  • "We are pleased to welcome Jiayi and Saumya to the PathAI Biopharma leadership team," said Mike Montalto, PhD, Chief Scientific Officer and President of PathAI's Biopharma Business.
  • Prior to PathAI, Saumya built and led translational and clinical genomics at Bristol Myers Squibb over the last 7 years.
  • Jiayi Hao joins PathAI as VP of Strategy and Operations for PathAI's Biopharma business.